Position in ADMA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$762,013
-$145,239 QoQ
Shares Held
91,041
-9.6% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#115
of 321 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Motley Fool Asset Management LLC holds $16,682,515 across 10 Biotechnology names. ADMA ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,288 | $8,587,468 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,170 | $2,760,445 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
70,651 | $2,359,036 | |
| 4 | ADMA |
Adma Biologics, Inc.
This page
|
91,041 | $762,013 | |
| 5 | EXEL |
Exelixis, Inc.
|
8,708 | $473,802 | |
| 6 | MRNA |
Moderna, Inc.
|
6,721 | $470,671 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
1,551 | $379,638 | |
| 8 | INCY |
Incyte Corp
|
3,291 | $373,067 |
All Filings in ADMA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $762,013 | 91,041 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $907,252 | 100,694 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,962,423 | 107,589 | Shares | Sole | 2026-02-11 | |
| 2020-09-30 | $1,717,924 | 718,797 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,966,709 | 671,232 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,765,719 | 613,097 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||